scispace - formally typeset
R

Roby J. Jose

Researcher at James Cook University

Publications -  17
Citations -  497

Roby J. Jose is an academic researcher from James Cook University. The author has contributed to research in topics: Angiotensin II & Aortic aneurysm. The author has an hindex of 12, co-authored 17 publications receiving 407 citations. Previous affiliations of Roby J. Jose include Federation University Australia & L V Prasad Eye Institute.

Papers
More filters
Journal ArticleDOI

A Peptide Antagonist of Thrombospondin-1 Promotes Abdominal Aortic Aneurysm Progression in the Angiotensin II–Infused Apolipoprotein-E–Deficient Mouse

TL;DR: Attenuation of thrombospondin-1-directed activation of TGF-&bgr;1 promotes abdominal aortic aneurysm and atherosclerosis progression in the angiotensin II–infused ApoE−/− mouse model.
Journal ArticleDOI

Everolimus Limits Aortic Aneurysm in the Apolipoprotein E–Deficient Mouse by Downregulating C-C Chemokine Receptor 2 Positive Monocytes

TL;DR: Systemic administration of everolimus limits aortic aneurysm in the A2-infused apolipoprotein E–deficient mouse model via suppressed development of bone marrow CCR2 monocytes and reduced egress of these cells into the circulation.
Journal ArticleDOI

Diagnosis of herpes simplex virus-1 keratitis: Comparison of Giemsa stain, immunofluorescence assay and polymerase chain reaction

TL;DR: A combination of PCR and immunofluorescence assay appears to be the most suitable choice of tests for diagnosis of HSV-1 keratitis, while detection of MNGC by Giemsa staining procedure may give a presumptive diagnosis of suspected viral infection.
Journal ArticleDOI

Osteoprotegerin Deficiency Limits Angiotensin II–Induced Aortic Dilatation and Rupture in the Apolipoprotein E–Knockout Mouse

TL;DR: Findings support a role for osteoprotegerin in aortic aneurysm through upregulation of CTSS, matrix metalloproteinase 2, and matrix meetingallop Proteinase 9 within the aorta, promoting an inflammatory phenotype in aortsic vascular smooth muscle cells in response to angiotensin II.